Profile data is unavailable for this security.
About the company
Zhejiang Hisun Pharmaceutical Co., Ltd. is a China-based company, principally engaged in the research and development, manufacture and distribution of specialty bulk pharmaceutical chemicals and preparation products. The Company's bulk pharmaceutical chemicals mainly include antineoplastic drugs, cardiovascular drugs, anti-infection drugs, endocrine control drugs, anthelmintic, as well as animal remedies, among others. The Company is also engaged in the sales of drugs manufactured by other companies. The Company distributes its products in domestic markets and to overseas markets.
- Revenue in CNY (TTM)9.56bn
- Net income in CNY-77.34m
- Incorporated1998
- Employees8.06k
- LocationZhejiang Hisun Pharmaceutical Co LtdNo. 46, Waisha Road, Jiaojiang DistrictTAIZHOU 318000ChinaCHN
- Phone+86 57 185278141
- Fax+86 57 688827887
- Websitehttp://www.hisunpharm.com
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| North China Pharmaceutical Co Ltd | 10.12bn | 50.33m | 7.81bn | 10.16k | 155.08 | 1.46 | -- | 0.7716 | 0.0293 | 0.0293 | 5.90 | 3.11 | 0.4721 | 2.78 | 4.30 | 995,956.10 | 0.4856 | -0.2978 | 1.14 | -0.7042 | 29.56 | 35.73 | 1.03 | -0.5985 | 0.5403 | 1.54 | 0.6491 | -- | -3.62 | 1.89 | 100.71 | -49.62 | 4.22 | -19.73 |
| Aurisco Pharmaceutical Co Ltd | 1.44bn | 382.11m | 8.20bn | 1.52k | 21.63 | 3.94 | -- | 5.69 | 0.9328 | 0.9328 | 3.50 | 5.12 | 0.5744 | 1.15 | 5.11 | 947,099.20 | 15.19 | 12.40 | 19.04 | 14.33 | 58.12 | 51.26 | 26.44 | 23.05 | 1.33 | -- | 0.1447 | 25.15 | 25.24 | 17.02 | 37.23 | 16.16 | 26.54 | -- |
| GuangYuYuan Chinese Herbal Medicn Co Ltd | 1.28bn | 139.62m | 8.20bn | 1.81k | 58.72 | 5.27 | -- | 6.41 | 0.2852 | 0.2852 | 2.61 | 3.18 | 0.5043 | 0.6114 | 2.37 | 706,662.60 | 6.01 | -2.10 | 8.95 | -3.16 | 72.86 | 69.74 | 11.91 | -6.00 | 1.05 | 16.41 | 0.0597 | -- | 13.56 | -4.53 | 136.03 | -24.78 | -58.35 | -- |
| Chongqing Genrix Biophrmctcl Co Ltd | 1.09m | -775.10m | 8.24bn | 547.00 | -- | 3.30 | -- | 7,552.93 | -2.11 | -2.11 | 0.003 | 6.81 | 0.0003 | 0.0628 | 53.97 | 1,995.17 | -20.89 | -- | -21.71 | -- | -214.22 | -- | -71,021.27 | -- | 20.06 | -- | 0.2053 | -- | 154.92 | -- | -39.03 | -- | -- | -- |
| Zhejiang Hisun Pharmaceutical Co., Ltd. | 9.56bn | -77.34m | 8.50bn | 8.06k | -- | 1.05 | -- | 0.8898 | -0.0788 | -0.0788 | 8.09 | 6.72 | 0.5421 | 3.36 | 4.06 | 1,185,368.00 | -0.5337 | 1.95 | -0.8961 | 3.77 | 38.03 | 40.58 | -0.9846 | 3.43 | 0.6209 | 2.46 | 0.397 | 26.07 | -13.82 | 0.3618 | -119.05 | -- | -31.58 | -- |
| Changchun BCHT Biotechnology Co | 1.88bn | 527.23m | 9.06bn | 1.24k | 17.16 | 2.20 | -- | 4.81 | 1.28 | 1.28 | 4.56 | 9.96 | 0.394 | 0.7747 | 1.53 | 1,517,684.00 | 11.03 | 9.95 | 13.51 | 12.81 | 89.44 | 86.63 | 27.99 | 24.03 | 1.99 | -- | 0.0252 | 10.55 | 70.30 | 12.36 | 175.98 | 31.37 | 21.04 | -- |
Data as of Sep 13 2024. Currency figures normalised to Zhejiang Hisun Pharmaceutical Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
2.48%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Yinhua Fund Management Co., Ltd.as of 31 Dec 2023 | 7.67m | 0.70% |
| GF Fund Management Co., Ltd.as of 31 Dec 2023 | 4.85m | 0.44% |
| HSBC Jintrust Fund Management Co. Ltd.as of 31 Dec 2023 | 3.20m | 0.29% |
| The Vanguard Group, Inc.as of 31 Jul 2024 | 2.80m | 0.26% |
| China Southern Asset Management Co., Ltd.as of 31 Dec 2023 | 2.33m | 0.21% |
| Fullgoal Fund Management Co., Ltd.as of 31 Dec 2023 | 1.59m | 0.15% |
| Da Cheng Fund Management Co., Ltd.as of 31 Dec 2023 | 1.57m | 0.14% |
| China Asset Management Co., Ltd.as of 31 Dec 2023 | 1.47m | 0.13% |
| Dimensional Fund Advisors LPas of 05 Sep 2024 | 857.90k | 0.08% |
| China Merchants Fund Management Co., Ltd.as of 31 Dec 2023 | 688.70k | 0.06% |
More ▼
Data from 31 Dec 2023 - 30 Jun 2024Source: FactSet Research Systems Inc.
